Home / Stocks / IOBT

IOBT insider trading

IO Biotech, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$76k
Buys · last 90 days
0 · $0
Most recent buy
2025-06-02

Cluster buy detected

4 insiders bought IOBT within a short window (2024-12-23), $55k in total — cluster score 65/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-06-02Hunter Heidi
Director
Bought15,000$1.39$21k
2024-12-26Ahmad Qasim Iftikharcluster
Chief Medical Officer
Bought31,350$0.85$27k
2024-12-23Zocca Mai-Brittcluster
Chief Executive Officer
Bought12,500$0.81$10k
2024-12-23Sullivan Amycluster
Chief Financial Officer
Bought10,250$0.83$9k
2024-12-23Smith Devin Whittemorecluster
General Counsel
Bought12,000$0.81$10k

Most active insider buyers

InsiderRoleBuysTotal bought
Ahmad Qasim IftikharChief Medical Officer1$27k
Hunter HeidiDirector1$21k
Zocca Mai-BrittChief Executive Officer1$10k
Smith Devin WhittemoreGeneral Counsel1$10k
Sullivan AmyChief Financial Officer1$9k

See IOBT on the chart

Every insider buy and sell for IOBT plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.